Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP42902.RAquhtaxQBHUp6Fcd2FuRz5xXVDOnqFcdw_JngMmCM88c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP42902.RAquhtaxQBHUp6Fcd2FuRz5xXVDOnqFcdw_JngMmCM88c130_assertion type Assertion NP42902.RAquhtaxQBHUp6Fcd2FuRz5xXVDOnqFcdw_JngMmCM88c130_head.
- NP42902.RAquhtaxQBHUp6Fcd2FuRz5xXVDOnqFcdw_JngMmCM88c130_assertion description "[Therefore, polymorphisms of genes encoding enzymes involved in estrogen biosynthesis pathway and in the metabolic activation of pro-carcinogens to genotoxic intermediates, such as cytochrome P450C17alpha (CYP17), endogenous free-radical scavenging systems, such as glutathione S-transferase (GSTP1) and paraoxonase 1 (PON1), and anti-glycation defenses, such as glyoxalase I (GLO1), could influence individual susceptibility to BC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP42902.RAquhtaxQBHUp6Fcd2FuRz5xXVDOnqFcdw_JngMmCM88c130_provenance.
- NP42902.RAquhtaxQBHUp6Fcd2FuRz5xXVDOnqFcdw_JngMmCM88c130_assertion evidence source_evidence_literature NP42902.RAquhtaxQBHUp6Fcd2FuRz5xXVDOnqFcdw_JngMmCM88c130_provenance.
- NP42902.RAquhtaxQBHUp6Fcd2FuRz5xXVDOnqFcdw_JngMmCM88c130_assertion SIO_000772 19379515 NP42902.RAquhtaxQBHUp6Fcd2FuRz5xXVDOnqFcdw_JngMmCM88c130_provenance.
- NP42902.RAquhtaxQBHUp6Fcd2FuRz5xXVDOnqFcdw_JngMmCM88c130_assertion wasDerivedFrom gad-20130706 NP42902.RAquhtaxQBHUp6Fcd2FuRz5xXVDOnqFcdw_JngMmCM88c130_provenance.
- NP42902.RAquhtaxQBHUp6Fcd2FuRz5xXVDOnqFcdw_JngMmCM88c130_assertion wasGeneratedBy ECO_0000203 NP42902.RAquhtaxQBHUp6Fcd2FuRz5xXVDOnqFcdw_JngMmCM88c130_provenance.